MeSH tree: C04.557.450.565.465
Dana-Farber Cancer Institute researchers are breaking new ground in the fight against systemic mastocytosis, a rare and heterogeneous condition that is often challenging for clinicians to accurately diagnose and treat.
Dec 9, 2024
0
0
A new research paper titled "Prevalence and impact of the KIT M541L variant in patients with mastocytosis" has been published in Oncotarget.
Jul 24, 2024
0
0
In a practice parameter update published online Dec. 17 in the Annals of Allergy, Asthma & Immunology, new guidelines are presented for the diagnosis and management of anaphylaxis.
Dec 27, 2023
0
22
The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis, according to results ...
Dec 11, 2023
0
0
